Benzinga

77531.491.3107%

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

77531.491.3107%

Relay Therapeutics Inc Stock News

RLAYNASDAQ

Trade with Public

Trade with Public

$18.65

0.271.47%

Last update: Sep 1, 1:07 PM

OverviewNewsEarnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Latest Relay Therapeutics Stock News | NASDAQ:RLAY | Benzinga

Get the latest news on Relay Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Relay Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, August 20, 2026

PRO
HC Wainwright & Co. Maintains Buy on Relay Th...
Benzinga Newsdesk

Friday, August 14, 2026

PRO
JP Morgan Maintains Overweight on Relay Thera...
Benzinga Newsdesk

Monday, August 10, 2026

PRO
Citizens Maintains Market Outperform on Relay...
Benzinga Newsdesk

Friday, August 07, 2026

PRO
Barclays Maintains Overweight on Relay Therap...
Benzinga Newsdesk

Thursday, August 06, 2026

PRO
Relay Therapeutics Q2 EPS $(0.41) Misses $(0....
Benzinga Newsdesk

Tuesday, July 21, 2026

PRO
Goldman Sachs Maintains Buy on Relay Therapeu...
Benzinga Newsdesk

Thursday, July 16, 2026

PRO
Canaccord Genuity Initiates Coverage On Relay...
Benzinga Newsdesk

Wednesday, July 08, 2026

PRO
JP Morgan Initiates Coverage On Relay Therape...
Benzinga Newsdesk

Tuesday, May 26, 2026

PRO
Guggenheim Maintains Buy on Relay Therapeutic...
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on Relay Th...
Benzinga Newsdesk

Thursday, May 21, 2026

PRO
Relay Therapeutics shares are trading higher....
Benzinga Newsdesk
Advance Auto Parts Posts Upbeat Q1 Earnings, Joins IBM, Ralph Lauren And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
PRO
Reported Earlier, Relay Therapeutics Prices 2...
Benzinga Newsdesk

Wednesday, May 20, 2026

PRO
Relay Therapeutics shares are trading higher ...
Benzinga Newsdesk
PRO
Barclays Maintains Overweight on Relay Therap...
Benzinga Newsdesk
PRO
Citizens Maintains Market Outperform on Relay...
Benzinga Newsdesk
Lowe's, ZTO Express, Viavi Solutions And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor

Tuesday, May 19, 2026

PRO
Relay Therapeutics Launches $175M Public Stoc...
Benzinga Newsdesk
PRO
Raymond James Maintains Strong Buy on Relay T...
Benzinga Newsdesk
Relay Therapeutics Reports Early Success For Investigational Drug In Rare Vascular Disorders
Vandana Singh
PRO
Relay Therapeutics shares are trading higher ...
Benzinga Newsdesk
PRO
Relya Therapeutics Announces Initial Clinical...
Benzinga Newsdesk

Tuesday, May 05, 2026

PRO
Relay Therapeutics Q1 EPS $(0.41) Misses $(0....
Benzinga Newsdesk
Earnings Scheduled For May 5, 2026
Benzinga Insights

Wednesday, April 29, 2026

Starbucks To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
PRO
HC Wainwright & Co. Maintains Buy on Relay Th...
Benzinga Newsdesk

Tuesday, April 28, 2026

PRO
Goldman Sachs Maintains Buy on Relay Therapeu...
Benzinga Newsdesk
PRO
Citizens Maintains Market Outperform on Relay...
Benzinga Newsdesk
PRO
Wells Fargo Maintains Overweight on Relay The...
Benzinga Newsdesk
PRO
Oppenheimer Maintains Outperform on Relay The...
Benzinga Newsdesk

Monday, April 27, 2026

PRO
Relay Therapeutics Plans To Move Zovegalisib ...
Benzinga Newsdesk

Tuesday, April 14, 2026

PRO
Jones Trading Initiates Coverage On Relay The...
Benzinga Newsdesk

Wednesday, April 08, 2026

PRO
Barclays Maintains Overweight on Relay Therap...
Benzinga Newsdesk

Thursday, April 02, 2026

PRO
Relay Therapeutics To Present Initial Clinica...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights

Monday, March 23, 2026

PRO
HC Wainwright & Co. Maintains Buy on Relay Th...
Benzinga Newsdesk

Tuesday, March 17, 2026

PRO
Citizens Maintains Market Outperform on Relay...
Benzinga Newsdesk
PRO
Wells Fargo Maintains Overweight on Relay The...
Benzinga Newsdesk

Monday, March 16, 2026

Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?
Vandana Singh
PRO
Relay Therapeutics Announces Data From Phase ...
Benzinga Newsdesk

Friday, March 13, 2026

PRO
Guggenheim Maintains Buy on Relay Therapeutic...
Benzinga Newsdesk

Friday, February 27, 2026

PRO
Wells Fargo Maintains Overweight on Relay The...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
PRO
Relay Therapeutics shares are trading higher ...
Benzinga Newsdesk

Thursday, February 26, 2026

Relay Therapeutics Q4 Earnings Assessment
Benzinga Insights
PRO
Relay Therapeutics Q4 EPS $(0.32) Beats $(0.3...
Benzinga Newsdesk
Earnings Scheduled For February 26, 2026
Benzinga Insights

Wednesday, February 25, 2026

Relay Therapeutics Earnings Preview
Benzinga Insights

Tuesday, February 03, 2026

PRO
The FDA Grants Breakthrough Therapy Designati...
Benzinga Newsdesk

Monday, January 26, 2026

PRO
Oppenheimer Upgrades Relay Therapeutics to Ou...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Gilead Sciences Inc

Vertex Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc

Revolution Medicines Inc

BeOne Medicines Ltd